Evaluating the impact of treating the optimal subgroup

@article{Luedtke2017EvaluatingTI,
  title={Evaluating the impact of treating the optimal subgroup},
  author={A. Luedtke and M. van der Laan},
  journal={Statistical Methods in Medical Research},
  year={2017},
  volume={26},
  pages={1630 - 1640}
}
Suppose we have a binary treatment used to influence an outcome. Given data from an observational or controlled study, we wish to determine whether or not there exists some subset of observed covariates in which the treatment is more effective than the standard practice of no treatment. Furthermore, we wish to quantify the improvement in population mean outcome that will be seen if this subgroup receives treatment and the rest of the population remains untreated. We show that this problem is… Expand
Predictive approaches to heterogeneous treatment effects: a systematic review
TLDR
Three classes of approaches were identified to assess heterogeneity of treatment effect within a randomized clinical trial, and methodological research is required to compare the available methods in different settings and to derive well-informed guidance for their application in RCT analysis. Expand
Predictive approaches to heterogeneous treatment effects: a scoping review
TLDR
This work aimed to identify regression modeling approaches that assess heterogeneity of treatment effect within a randomized clinical trial by performing a literature review using a broad search strategy, complemented by suggestions of a technical expert panel. Expand
Machine learning methods for developing precision treatment rules with observational data.
TLDR
A tiered case-cohort design approach that uses innovative methods for measuring and balancing baseline covariates and estimating PTRs to address the sample size problem and the major challenges are that treatment are not randomly assigned in observational databases and that these databases often lack measures of key prescriptive predictors and mental disorder treatment outcomes. Expand
Methodological issues in psychological treatment research : applications to gambling research and therapist effects
Over the last couple of decades evidence-based psychotherapies have flourished, and there are now therapies that are well-established for a wide range of problems. At the same time the mental-healthExpand
An individualized treatment rule to optimize probability of remission by continuation, switching, or combining antidepressant medications after failing a first-line antidepressant in a two-stage randomized trial.
TLDR
An ITR for depression remission can be developed to improve second-line antidepressant selection, but replication in a larger study with more comprehensive baseline predictors might produce stronger and more stable results. Expand
The potential of predictive analytics to provide clinical decision support in depression treatment planning
  • R. Kessler
  • Psychology, Medicine
  • Current opinion in psychiatry
  • 2018
TLDR
Recommendations include using large prospective observational studies followed by pragmatic trials rather than smaller, expensive controlled treatment trials for preliminary development of decision support tools; basing these tools on comprehensive batteries of inexpensive self-report and clinical predictors (e.g., self-administered performance-based neurocognitive tests) versus expensive biomarkers. Expand
A Preliminary Precision Treatment Rule for Remission of Suicide Ideation.
TLDR
Results are limited by the small sample size, restrictive baseline assessment, and inability to evaluate effects on suicidal behaviors or disaggregate based on history of suicidal behaviors, so replication is needed in larger samples with comprehensive baseline assessments, longer-term follow-ups, and more extensive outcomes. Expand
New directions in machine learning analyses of administrative data to prevent suicide-related behaviors.
TLDR
Call for ML SRB research to move beyond merely demonstrating significant prediction, and to focus instead on using such models to target specific preventive interventions and to develop individualized treatment rules that can be used to help guide clinical decisions that address the growing problems of suicide attempts, suicide deaths, and other injuries and deaths in the same spectrum. Expand
Using Administrative Data to Predict Suicide After Psychiatric Hospitalization in the Veterans Health Administration System
TLDR
A risk model to predict which inpatients might need intensive postdischarge case management and prospects for developing a parallel precision treatment model is developed for US veterans in VHA hospitals 2010–2013. Expand
Deeply-Debiased Off-Policy Interval Estimation
TLDR
A novel deeply-debiasing procedure is proposed to construct an efficient, robust, and flexible CI on a target policy’s value that quantifies the uncertainty of the point estimate. Expand
...
1
2
...

References

SHOWING 1-10 OF 34 REFERENCES
Optimal Individualized Treatments in Resource-Limited Settings
TLDR
This work presents an estimator of the mean outcome under the optimal stochastic ITR in a large semiparametric model that at most places restrictions on the probability of treatment assignment given covariates and gives conditions under which this estimator is efficient among all regular and asymptotically linear estimators. Expand
Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification.
TLDR
Although randomization theoretically ensures the comparability of treatment groups overall, there remain important differences between individuals in each treatment group that can dramatically affect the likelihood of benefiting from or being harmed by a therapy. Expand
STATISTICAL INFERENCE FOR THE MEAN OUTCOME UNDER A POSSIBLY NON-UNIQUE OPTIMAL TREATMENT STRATEGY.
TLDR
An approach to obtain root-n rate confidence intervals for the optimal value even when the parameter is not pathwise differentiable is described, and conditions under which the estimator is RAL and asymptotically efficient when the mean outcome is path Wise differentiable are provided. Expand
Targeted Learning of the Mean Outcome under an Optimal Dynamic Treatment Rule
TLDR
A novel cross-validated TMLE approach is developed that provides asymptotic inference under minimal conditions, avoiding the need for any empirical process conditions, and develops a targeted minimum loss-based estimator of this target parameter. Expand
Targeted Learning of an Optimal Dynamic Treatment, and Statistical Inference for its Mean Outcome
Suppose we observe n independent and identically distributed observations of a time-dependent random variable consisting of baseline covariates, initial treatment and censoring indicator,Expand
Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials.
TLDR
Examining the architecture of the entire set of subgroups within a trial, analyzing similar subgroups across independent trials, and interpreting the evidence in the context of known biologic mechanisms and patient prognosis are recommended. Expand
Optimal Dynamic Treatments in Resource-Limited Settings
A dynamic treatment rule (DTR) is a treatment rule which assigns treatments to individuals based on (a subset of) their measured covariates. An optimal DTR is the DTR which maximizes the populationExpand
Inference about the expected performance of a data-driven dynamic treatment regime
TLDR
A conceptually simple and computationally feasible method for constructing valid CIs for the Value of an estimated DTR based on subsampling, which offers considerable improvement in terms of coverage rates of the CIs over the standard bootstrap approach. Expand
Subgroup analysis in randomised controlled trials: importance, indications, and interpretation
TLDR
Subgroup analyses are important if there are potentially large differences between groups in the risk of a poor outcome with or without treatment, if there is potential heterogeneity of treatment effect in relation to pathophysiology, or ifthere are practical questions about when to treat. Expand
Subgroup analysis and other (mis)uses of baseline data in clinical trials
TLDR
Clinical trials need a predefined statistical analysis plan for uses of baseline data, especially covariate-adjusted analyses and subgroup analyses, and investigators and journals need to adopt improved standards of statistical reporting, and exercise caution when drawing conclusions from subgroup findings. Expand
...
1
2
3
4
...